You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

ID: MOTAC-7 jan 2025
Type of Content: Guidelines & Advice
Document Status: Current
Authors:
S. Saibil, X. Yao, D. Sivajohanathan, M. Deodat, M Vickers, P. Wheatley-Price, J. Yoon, H. Feilotter

Guideline Objective

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary.

Patient Population

All adult patients with a diagnosis of CUP.

Intended Guideline Users

  • Clinicians, laboratory physicians, and scientists involved in the care and testing of patients with cancers of unknown primary
  • Policy makers, health care administrators, and the OMH

Research Questions

Can clinical outcomes, such as OS and PFS, and/or diagnostic outcomes (such as sensitivity and specificity) be improved through molecular profiling in patients with a diagnosis of cancer of unknown primary.

pdf download Full Report (PDF) (1.07 Mo)